Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Molecular Templates
company
About
Molecular Templates develops novel therapeutic compounds for cancer.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$60.15M
Molecular Templates has raised a total of
$60.15M
in funding over 2 rounds. Their latest funding was raised on
Aug 16, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 16, 2017 | Post-IPO Equity | $60M | 1 | — | — | Detail |
| Jan 1, 2010 | Grant | $153.93K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Molecular Templates is funded by 2 investors.
Takeda
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
— | Post-IPO Equity |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
